NPPB and COVID-19: The prospective studies in 1-year post-COVID-19, including patients infected with alfa and beta SARS-CoV-2 variants, with mild (74%), moderate (4.8%), severe (18.1%), and critical (2.9%) forms of disease, found persistent levels of troponin and NT-proBNP, while LVEF had not significantly decreased [39].